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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S276association of future pain with X-ray features can be used to develop a
prevention strategy for chronic pain. The public health systems can be
beneﬁciate with the use of a radiological Biomarker.
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SYNOVITIS IS ASSOCIATED WITH BONE MARROW ABNORMALITY IN
PATIENT WITH END-STAGE KNEE OSTEOARTHRITIS
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Purpose: The degeneration and destruction of articular cartilage are
associated with the progression of osteoarthritis (OA). However, the
pain and a loss of joint function which are characteristics of OA are not
correlated with the extent of degeneration and destruction of articular
cartilage. Synovitis in OA may be a secondary phenomenon related to
cartilage alterations induced by the release of degenerative compounds
from the extracellular matrix of articular cartilage and, presumably,
bone. This could further stimulate cartilage damage. Recently, the role
of synovitis in OA has attracted particular attention, as synovitis has
been revealed to be one of the potential predictive factors for both
structural and symptomatic progression of the disease, thus indicating
its crucial role in the pathophysiology of OA. However, most of the
studies focused on synovitis in OA were conducted to the patients with
early to moderate stage of knee OA. We previously revealed the dis-
ability of patients with end-stage of knee OAwho required TKA showed
a signiﬁcant correlation with the severity of synovitis in affected knee
joint. However, it’s still remained unclear whether synovitis is also
related to cartilage alterations in end-stage of knee OA, where articular
cartilage is almost disappeared. The aim of our study was to investigate
whether the joint abnormalities occurred in knee OA detected by MRI
were associated with synovitis evaluated by histological analysis in
patient with end-stage knee OA.
Methods: This study protocol was approved by the institutional review
board of our university. Sixty patients with end-stage knee OA (female:
53, male: 7, 70.1y on average) who undergoing TKA were enrolled. All
participants were performed with 1.5-Tesla MRI system. OA changes,
such as (1) cartilage morphology, (2) BMAs, (3) bone cysts, (4) bone
attrition, (5) meniscal pathology and (6) osteophytes, were scored using
the whole-organ MRI scoring method (WORMS) as reported previously.
The synovial samples were obtained during the operation from ﬁve
regions of interest (ROIs). These ROIs included 3 in the suprapatellar
recess (lateral recess [ROI 1], medial recess [ROI 2], and just above the
trochlear groove [ROI 5]) and 1 each in the lateral and medial femoral
gutters (ROIs 3 and 4, respectively). Six histological parameters were:
(1) the thickness of synovial lining layer, (2) subsynovial inﬁltration by
lymphocytes and plasma cells, (3) surface ﬁbrin deposition, (4) blood
vessel vasodilation and blood vessel proliferation, (5) ﬁbrosis, and (6)
perivascular edema. The parameters were graded as follows: 0 ¼ none;
1 ¼ mild; 2 ¼ moderate; 3 ¼ severe.
Results: A simple regression analysis was performed between each
histological total scores and WORMS scores. While cartilage morphol-
ogy scores, bone cyst scores, bone attrition scores, meniscal pathology,
and osteophyte scores were not associated with histological total scores
and its subcategory scores. On the other hand, BMA total score were
signiﬁcantly associated with histology total score (r ¼ 0.641, p ¼ 0.019).
All patients showed BMA in medial femoro-tibial joint (MFTJ). On the
other hand, twenty-six of sixty patients and sixteen of sixty patients did
not show BMA in lateral femoro-tibial joint (LFTJ) and patella-femoral
joint (PFJ), respectively. No signiﬁcant differences of the MFTJ histology
scores (ROI2þROI4) in patients with BMA in LFTJ in comparison to those
in patients without BMA in LFTJ (p ¼ 0.52). LFTJ histology scores(ROI1þROI3) of the patients with BMA in confronting LTFJ were sig-
niﬁcantly increased in comparison to those of patients without BMA in
this lesion (p < 0.001). Similarly, PFJ histology score (ROI5) of the
patients with BMA in confronting PFJ were also signiﬁcantly increased
in comparison to those of patients without BMA in this lesion (p <
0.001). Furthermore, total histological scores (SUM of ROI1 to ROI5) in
patients with BMA in LFTJ were signiﬁcantly increased in comparison to
those in patients without BMA in LFTJ (p < 0.001).
Conclusions: Synovitis in OA is associated with the severity of pain in
patients with primary through end-stage of knee OA. However, whether
synovitis is related to cartilage alterations in end-stage of knee OA is
unclear. BMAs are ﬁndings with a high signal intensity in the T2-
weighted fat-suppressed images. BMAs have been also linked to pain,
cartilage defects, and a progression of cartilage loss. However, the
pathogenesis of BMA is still unknown. The present study indicates for
the ﬁrst time the association between the BMA and synovitis in patients
with end-stage of knee OA.
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Purpose: To non-invasively diagnose knee osteoarthritis (OA) in
an early stage of disease, to follow subtle disease progression over
time and to assess the efﬁcacy of potential novel treatment
strategies for OA, quantitative radiological measurements of car-
tilage composition have become of interest. Delayed gadolinium-
enhanced MRI of cartilage, T1rho-, T2-mapping, sodium imaging
and gagCEST are examples of MRI based techniques to measure
cartilage sulphated glycosaminoglycan (sGAG) or collagen content.
Recently, the ability of CT arthrography (CTa) to quantitatively
measure knee cartilage composition in terms of its sGAG content
has been demonstrated in an ex-vivo study using human cadaveric
knee joints. Since a validation study comparing in-vivo acquired
CTa outcomes against ex-vivo reference standards for
cartilage composition has not yet been performed, the aim of the
present study was to perform such a validation in humans with
knee OA.
Methods: We analyzed data of 12 patients from an ongoing study in
which knee OA patients (Kellgren and Lawrence grade 2-4) undergo
CTa before total knee replacement (TKR). Mean X-ray attenuation
values were calculated in 6 regions of interest (ROI) of the articular
cartilage (medial and lateral weight-bearing (WB) femoral condyles
and tibial plateaus and non-WB cartilage of the condyles) (Fig. 1).
Femoral and tibial cartilage was harvested during TKR and rescanned
with contrast-enhanced microCT (CE-uCT). Mean CE-uCT X-ray
attenuation values served as surrogate reference standard for carti-
lage sGAG content since it has been shown to accurately measure
sGAG content compared to a reference standard for cartilage com-
position. We analyzed the correlation between mean CTa X-ray
attenuation and mean CE-uCT X-ray attenuation with linear
regression.
Results: Mean X-ray attenuation values of the different ROIs in the
medial tibiofemoral joint ranged from 177 to 455 Hounsﬁeld Units
and from 151 to 454 Hounsﬁeld Units in the lateral tibiofemoral
compartment. Outcomes of CTa had a strong correlation with ref-
erence CE-uCT X-ray attenuation, representing sGAG content of
articular cartilage in the femoral cartilage (r ¼ 0.79; p<0.0001; r^2
¼ 0.63) (Fig. 2A), in the tibial cartilage (r ¼ 0.75; p<0.0001; r^2 ¼
0.58) (Fig. 2B) and in the tibiofemoral cartilage (r ¼ 0.78; p<0.0001;
r^2 ¼ 0.61) (Fig. 2C).
